Ads
related to: simvastatin 80 mg not recommended dosage for adults over 50 plus one- Dosing & Administration
Efficacy, Safety, and Dosing
Information for HCPs
- Co-Pay Program
Resources
to Support Your Patients
- Trial Results
See Clinical Data
and Trial
- Patient Identification
View a Patient Profile
to Learn More
- Safety
Safety Profile - Learn About
Adverse Patient Reactions
- Request Samples
Get patients started
with a 14-day sample
- Dosing & Administration
consumereview.org has been visited by 100K+ users in the past month
nexlizet.com has been visited by 100K+ users in the past month
Search results
Results From The WOW.Com Content Network
Simvastatin is an effective serum lipid-lowering drug that can decrease low density lipoprotein (LDL) levels by up to 50%. [ citation needed ] Simvastatin had been shown to interact with lipid-lowering transcription factor PPAR-alpha [ 36 ] and that interaction might control the neurotrophic action of the drug.
They recommended selective use of low-to-moderate doses statins in the same adults who have a calculated 10-year cardiovascular disease event risk of 7.5–10% or greater. [23] In people over the age of 70, statins decrease the risk of cardiovascular disease but only in those with a history of heavy cholesterol blockage in their arteries. [25]
With median follow-up of 6 years, simvastatin+ezetimibe was found to reduce the primary outcome of CV mortality, major CV event, or nonfatal stroke (34.7% vs. 32.7%; P=0.016; NNT 50 per 7 years or NNT 350 per 1 year ). There was no reduction in all-cause or CV mortality with simvastatin+ezetimibe, though there was a reduction in MI and stroke. [6]
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.
[citation needed] Annual cost to the UK National Health Service (NHS) in 2018, for 5–40 mg rosuvastatin daily (of one person) was £24-40, compared to £10-20 for 20–80 mg simvastatin. [38] In 2013, it was the fourth-highest-selling drug in the United States, accounting for approximately $5.2 billion in sales. [39]
About one-quarter of U.S. adults over age 50 say they expect to never retire and 70% are concerned about prices rising faster than their income, an AARP survey finds. About 1 in 4 have no ...